BioCentury | Jun 22, 2020
Emerging Company Profile

Prosit Sole: chimeric proteins for rare disease

...Liu. Liu previously participated in the 2002 discovery of IFNλ as a senior scientist at ZymoGenetics Inc....
...VP of Research at ZymoGenetics and VP of Novo Nordisk’s Inflammation Research Center. In 2010, Zymogenetics...
BioCentury | May 1, 2019
Company News

Management tracks: Gilead, bluebird, Apollomics

...and Bruce Hart as VP of regulatory affairs. Hollywood was VP and head of the ZymoGenetics Inc....
BioCentury | Dec 1, 2017
Finance

Blue skies for Codiak

...most recently EVP of R&D at Biogen Inc. (NASDAQ:BIIB). Before that he was CEO of ZymoGenetics Inc....
BioCentury | Dec 1, 2016
Clinical News

Atacicept: Ph IIb ADDRESS II data

...in Washington, D.C. Merck has exclusive, worldwide rights to develop and commercialize atacicept from Bristol-Myers' ZymoGenetics Inc....
BioCentury | May 25, 2015
Strategy

You better you bet

...value is the same as that of a 2009 deal between Bristol-Myers Squibb Co. and ZymoGenetics Inc....
...Inc. for $11.2 billion, which included Phase III and Phase II programs. BMS eventually bought ZymoGenetics...
BioCentury | Jan 29, 2015
Strategy

PD-1 matchmaking

...of Maryland Cancer Preclin PD-L1 TIGIT Brigham and Women's Hospital Autoimmune Preclin Bristol-Myers Squibb Co. (ZymoGenetics Inc....
BioCentury | Feb 3, 2014
Clinical News

NovoThirteen catridecacog regulatory update

...6, 2014). Novo Nordisk has rights to the recombinant analogue of Factor XIII A-subunit from ZymoGenetics Inc....
BioCentury | Jan 6, 2014
Clinical News

Tretten recombinant coagulation Factor XIII A-subunit regulatory update

...EU, Switzerland and Australia as NovoThirteen catridecacog. Novo Nordisk has rights to the product from ZymoGenetics Inc....
BioCentury | Dec 24, 2013
Company News

FDA approves Novo product for congenital Factor XIII deficiency

...EU, Switzerland and Australia as NovoThirteen . Novo Nordisk has rights to the product from ZymoGenetics Inc....
BioCentury | Nov 11, 2013
Company News

Bristol-Myers pharmaceuticals news

...Inc. and ZymoGenetics Inc. in advance of announcements that the companies would be acquired. BMS acquired ZymoGenetics...
Items per page:
1 - 10 of 486
BioCentury | Jun 22, 2020
Emerging Company Profile

Prosit Sole: chimeric proteins for rare disease

...Liu. Liu previously participated in the 2002 discovery of IFNλ as a senior scientist at ZymoGenetics Inc....
...VP of Research at ZymoGenetics and VP of Novo Nordisk’s Inflammation Research Center. In 2010, Zymogenetics...
BioCentury | May 1, 2019
Company News

Management tracks: Gilead, bluebird, Apollomics

...and Bruce Hart as VP of regulatory affairs. Hollywood was VP and head of the ZymoGenetics Inc....
BioCentury | Dec 1, 2017
Finance

Blue skies for Codiak

...most recently EVP of R&D at Biogen Inc. (NASDAQ:BIIB). Before that he was CEO of ZymoGenetics Inc....
BioCentury | Dec 1, 2016
Clinical News

Atacicept: Ph IIb ADDRESS II data

...in Washington, D.C. Merck has exclusive, worldwide rights to develop and commercialize atacicept from Bristol-Myers' ZymoGenetics Inc....
BioCentury | May 25, 2015
Strategy

You better you bet

...value is the same as that of a 2009 deal between Bristol-Myers Squibb Co. and ZymoGenetics Inc....
...Inc. for $11.2 billion, which included Phase III and Phase II programs. BMS eventually bought ZymoGenetics...
BioCentury | Jan 29, 2015
Strategy

PD-1 matchmaking

...of Maryland Cancer Preclin PD-L1 TIGIT Brigham and Women's Hospital Autoimmune Preclin Bristol-Myers Squibb Co. (ZymoGenetics Inc....
BioCentury | Feb 3, 2014
Clinical News

NovoThirteen catridecacog regulatory update

...6, 2014). Novo Nordisk has rights to the recombinant analogue of Factor XIII A-subunit from ZymoGenetics Inc....
BioCentury | Jan 6, 2014
Clinical News

Tretten recombinant coagulation Factor XIII A-subunit regulatory update

...EU, Switzerland and Australia as NovoThirteen catridecacog. Novo Nordisk has rights to the product from ZymoGenetics Inc....
BioCentury | Dec 24, 2013
Company News

FDA approves Novo product for congenital Factor XIII deficiency

...EU, Switzerland and Australia as NovoThirteen . Novo Nordisk has rights to the product from ZymoGenetics Inc....
BioCentury | Nov 11, 2013
Company News

Bristol-Myers pharmaceuticals news

...Inc. and ZymoGenetics Inc. in advance of announcements that the companies would be acquired. BMS acquired ZymoGenetics...
Items per page:
1 - 10 of 486